395 related articles for article (PubMed ID: 17900562)
1. C-type natriuretic peptide stimulates pancreatic exocrine secretion in the rat: role of vagal afferent and efferent pathways.
Sabbatini ME; Rodríguez MR; Dabas P; Vatta MS; Bianciotti LG
Eur J Pharmacol; 2007 Dec; 577(1-3):192-202. PubMed ID: 17900562
[TBL] [Abstract][Full Text] [Related]
2. C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway.
Sabbatini ME; Rodríguez MR; Corbo NS; Vatta MS; Bianciotti LG
Eur J Pharmacol; 2005 Nov; 524(1-3):67-74. PubMed ID: 16263110
[TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system.
Sabbatini ME
Regul Pept; 2009 Apr; 154(1-3):5-15. PubMed ID: 19233231
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic factor stimulates exocrine pancreatic secretion in the rat through NPR-C receptors.
Sabbatini ME; Villagra A; Davio CA; Vatta MS; Fernandez BE; Bianciotti LG
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G929-37. PubMed ID: 12829435
[TBL] [Abstract][Full Text] [Related]
5. C-type natriuretic peptide enhances amylase release through NPR-C receptors in the exocrine pancreas.
Sabbatini ME; Rodríguez M; di Carlo MB; Davio CA; Vatta MS; Bianciotti LG
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G987-94. PubMed ID: 17702953
[TBL] [Abstract][Full Text] [Related]
6. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion.
Viard E; Zheng Z; Wan S; Travagli RA
Am J Physiol Gastrointest Liver Physiol; 2007 Aug; 293(2):G493-500. PubMed ID: 17569741
[TBL] [Abstract][Full Text] [Related]
7. Involvement of vagal nerves in the pancreatostimulatory effects of luminal melatonin, or its precursor L-tryptophan. Study in the rats.
Nawrot-Porabka K; Jaworek J; Leja-Szpak A; Szklarczyk J; Kot M; Mitis-Musioł M; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():81-95. PubMed ID: 18212402
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide.
Hobbs A; Foster P; Prescott C; Scotland R; Ahluwalia A
Circulation; 2004 Sep; 110(10):1231-5. PubMed ID: 15337698
[TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide inhibits L-type Ca2+ current in rat magnocellular neurosecretory cells by activating the NPR-C receptor.
Rose RA; Anand-Srivastava MB; Giles WR; Bains JS
J Neurophysiol; 2005 Jul; 94(1):612-21. PubMed ID: 15772242
[TBL] [Abstract][Full Text] [Related]
10. Activation of the dorsal vagal nucleus increases pancreatic exocrine secretion in the rat.
Mussa BM; Verberne AJ
Neurosci Lett; 2008 Mar; 433(1):71-6. PubMed ID: 18241988
[TBL] [Abstract][Full Text] [Related]
11. Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin.
Singer MV; Niebergall-Roth E
Cell Biol Int; 2009 Jan; 33(1):1-9. PubMed ID: 18948215
[TBL] [Abstract][Full Text] [Related]
12. Valsartan, a specific angiotensin II receptor blocker, inhibits pancreatic fluid secretion via vagal afferent pathway in conscious rats.
Yamamoto M; Wei L; Otani M; Harada M; Otsuki M
Regul Pept; 2012 Oct; 178(1-3):80-5. PubMed ID: 22796317
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor negatively modulates secretin intracellular signaling in the exocrine pancreas.
Sabbatini ME; Vatta MS; Davio CA; Bianciotti LG
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G349-57. PubMed ID: 16973919
[TBL] [Abstract][Full Text] [Related]
14. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
15. Bile secretion is centrally regulated by C-type natriuretic peptide.
Sabbatini ME; Vatta MS; Vescina C; Castro JL; Fernández BE; Bianciotti LG
Cell Mol Neurobiol; 2002 Dec; 22(5-6):755-70. PubMed ID: 12585693
[TBL] [Abstract][Full Text] [Related]
16. Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents.
Mussa BM; Sartor DM; Verberne AJ
Eur J Pharmacol; 2008 Dec; 601(1-3):198-206. PubMed ID: 19026634
[TBL] [Abstract][Full Text] [Related]
17. Central and peripheral neural control of pancreatic exocrine secretion.
Niebergall-Roth E; Singer MV
J Physiol Pharmacol; 2001 Dec; 52(4 Pt 1):523-38. PubMed ID: 11787756
[TBL] [Abstract][Full Text] [Related]
18. The vagal control of the pyloric motor function: a physiological and immunohistochemical study in cat and man.
Edin R
Acta Physiol Scand Suppl; 1980; 485():1-30. PubMed ID: 6163319
[TBL] [Abstract][Full Text] [Related]
19. NPR-C receptors are involved in C-type natriuretic peptide response on bile secretion.
Sabbatini ME; Vatta MS; Vescina C; Gonzales S; Fernandez B; Bianciotti LG
Regul Pept; 2003 Nov; 116(1-3):13-20. PubMed ID: 14599710
[TBL] [Abstract][Full Text] [Related]
20. Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats.
Yamamoto M; Otani M; Jia DM; Fukumitsu K; Yoshikawa H; Akiyama T; Otsuki M
Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G681-7. PubMed ID: 12801885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
